Filing Details

Accession Number:
0001209191-14-067760
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-10 20:05:08
Reporting Period:
2014-11-06
Filing Date:
2014-11-10
Accepted Time:
2014-11-10 20:05:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1010086 Siga Technologies Inc SIGA Pharmaceutical Preparations (2834) 133864870
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
740740 Macandrews & Forbes Llc 35 East 62Nd Street
New York NY 10065
Yes No Yes No
918939 Macandrews & Forbes Holdings Inc. 35 East 62Nd Street
New York NY 10065
Yes No Yes No
1186472 O Ronald Perelman 35 East 62Nd Street
New York NY 10065
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Acquisiton 2014-11-06 70,000 $1.46 13,379,995 No 4 P Indirect Owned through wholly-owned corporation
Common Stock, Par Value $.0001 Per Share Acquisiton 2014-11-07 129,727 $1.52 13,509,722 No 4 P Indirect Owned through wholly-owned corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Owned through wholly-owned corporation
No 4 P Indirect Owned through wholly-owned corporation
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $1.42 to $1.47. The price reported represents the weighted average purchase price of these trades. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares purchased at each separate price.
  2. Ronald O. Perelman, a joint filer hereunder, beneficially owns 100% of the common stock of MacAndrews & Forbes Holdings Inc. Certain direct or indirect wholly-owned subsidiaries of MacAndrews & Forbes Holdings Inc., including MacAndrews & Forbes LLC, a joint filer hereunder, hold the securities described above.
  3. This transaction was executed in multiple trades at prices ranging from $1.45 to $1.55. The price reported represents the weighted average purchase price of these trades. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares purchased at each separate price.